Status:
RECRUITING
Concordance and Acceptability of Self-screening Compared to Screening Carried Out by a Health Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV. A Randomized Controlled Crossover Study
Lead Sponsor:
Centre Hospitalier Universitaire de la Réunion
Conditions:
HPV
Eligibility:
FEMALE
30-65 years
Phase:
NA
Brief Summary
Comunity health actions are set up in populations of women aged 30 to 65 in vulnerable situations living in the outlying areas of Reunion Island. The idea is to evaluate those action on health
Eligibility Criteria
Inclusion
- Aged 30 to 65,
- In a vulnerable situation (beneficiary of a state or departmental social service, or referred by a charity),
- Resident in one of the two municipalities targeted by the study,
- Supported by the social services of one of the two municipalities targeted by the study,
- Having agreed to participate in sexual health awareness meetings organized on site
Exclusion
- Refusing to participate in the study
- Having had a hysterectomy
Key Trial Info
Start Date :
April 9 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07438080
Start Date
April 9 2025
End Date
March 1 2028
Last Update
February 27 2026
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cegidd Saint Paul
Saint-Paul, France
2
CegiDD Saint Pierre
Saint-Pierre, France